(Q40373406)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163378%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

title

Enhanced therapeutic efficacy of G207 for the treatment of glioma through Musashi1 promoter retargeting of gamma34.5-mediated virulence (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163378%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163378%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Kanai R

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163378%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Tomita H

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163378%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Shinoda A

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163378%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Takahashi M

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163378%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Okano H

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163378%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Kawase T

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163378%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Yazaki T

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163378%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163378%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163378%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163378%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163378%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

106-116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163378%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302636

6 January 2020

exact match

0 references

cites work

Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Viral shedding and biodistribution of G207, a multimutated, conditionally replicating herpes simplex virus type 1, after intracerebral inoculation in aotus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

The gamma 1(34.5) gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programed cell death in neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Musashi, a neural RNA-binding protein required for Drosophila adult external sensory organ development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Mouse-Musashi-1, a neural RNA-binding protein highly enriched in the mammalian CNS stem cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

The human Musashi homolog 1 (MSI1) gene encoding the homologue of Musashi/Nrp-1, a neural RNA-binding protein putatively expressed in CNS stem cells and neural progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Musashi1, an evolutionarily conserved neural RNA-binding protein, is a versatile marker of human glioma cells in determining their cellular origin, malignancy, and proliferative activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Expression of the neural RNA-binding protein Musashi1 in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

A novel multiply-mutated HSV-1 strain for the treatment of human brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Multidrug resistance in glioblastoma. Chemosensitivity testing and immunohistochemical demonstration of P-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

The intrinsic radioresistance of glioblastoma-derived cell lines is associated with a failure of p53 to induce p21(BAX) expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Cisplatin resistant glioblastoma cells may have increased concentration of urokinase plasminogen activator and plasminogen activator inhibitor type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Connexin 43-enhanced suicide gene therapy using herpesviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Double suicide gene therapy using a replication defective herpes simplex virus vector reveals reciprocal interference in a malignant glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Treatment of rat gliosarcoma brain tumors by HSV-based multigene therapy combined with radiosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Friendly fire: redirecting herpes simplex virus-1 for therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Herpes simplex virus gene products: the accessories reflect her lifestyle well

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Oncolytic herpes simplex virus vectors for cancer virotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Selective in vitro replication of herpes simplex virus type 1 (HSV-1) ICP34.5 null mutants in primary human CNS tumours--evaluation of a potentially effective clinical therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Proliferative activity and in vitro replication of HSV1716 in human metastatic brain tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Enhanced antitumor efficacy of a herpes simplex virus mutant isolated by genetic selection in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Oncogenes in Ras signalling pathway dictate host-cell permissiveness to herpes simplex virus 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Cell surface major histocompatibility complex class II proteins are regulated by the products of the gamma(1)34.5 and U(L)41 genes of herpes simplex virus 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Regulation of herpes simplex virus gamma(1)34.5 expression and oncolysis of diffuse liver metastases by Myb34.5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Identification of a putative intestinal stem cell and early lineage marker; musashi-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Canonical Wnt signals are essential for homeostasis of the intestinal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Expression of a functional foreign gene in adult mammalian brain following in Vivo transfer via a herpes simplex virus type 1 defective viral vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Expression of L1 in primary astrocytes via a defective herpes simplex virus vector promotes neurite outgrowth and neural cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Changes in ganglioside composition and morphological features during the development of cultured astrocytes from rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Activated Kupffer cells play an important role in intra-hepatic Th1-associated necro-inflammation in Concanavalin A-induced hepatic injury in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

Musashi1: an evolutionally conserved marker for CNS progenitor cells including neural stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

7 January 2021

High-yield selection and extraction of two promoter-defined phenotypes of neural stem cells from the fetal human brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

7 January 2021

B-myb promoter retargeting of herpes simplex virus gamma34.5 gene-mediated virulence toward tumor and cycling cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

7 January 2021

Recombinant herpes simplex virus type 1 engineered for targeted binding to erythropoietin receptor-bearing cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

1 reference

7 January 2021

Up-regulation of GADD34 mediates the synergistic anticancer activity of mitomycin C and a gamma134.5 deleted oncolytic herpes virus (G207).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

7 January 2021

Expression of neural RNA-binding proteins in the postnatal CNS: implications of their roles in neuronal and glial cell development.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302636

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302636

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163378%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

6 January 2020

1043813652

0 references

Fatcat ID

release_cgc6vmauhvfd5mxtajzmulugxu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cgc6vmauhvfd5mxtajzmulugxu

24 November 2022

mapped directly with Wikidata item

1 reference